Supplemental Figure S1 , relates to Figure 1: Cellular localization of endogenous PKD1 and pY397-FAK, and co-immunoprecipitation of ectopically expressed PKD1 and FAK. A, B: MCF-7 cells (0.10 x 10 6 cells /well, 24-well plate) were seeded on fibronectin-coated (2 μg/ml) glass coverslips and serumstarved for 16 hrs. Following serum-starvation, cells were stimulated with 10 μg/ml fibronectin or left untreated. After 30 minutes, cells were fixed and the localization of endogenous PKD1(Everest antibody in A; Abnova antibody in B) and pY397-FAK was determined by immunofluorescence analysis. Scale bars indicate 10 μm. Insets are 2.4-fold enhanced. C, D: Hek293T cells (0.5 x 10 6 cells/well, 6 well plate) in C, or NIH-3T3 cells (2 x 10 6 cells/10 cm dish) in D, were transfected with mCherry-FAK and vector control, FLAG-tagged wildtype PKD1 (PKD1) or FLAG-tagged constitutively-active PKD1 (PKD1.CA) as indicated. PKD1 was immunoprecipitated (anti-FLAG) and immunoprecipitates were analyzed for coimmunoprecipitated FAK. Samples were re-probed for overexpressed PKD1. Control Western blots of lysates were probed for FAK and β-actin expression. HeLa cells (0.65 x 10 6 cells/6 cm dish) were co-transfected with vector and FLAG-tagged constitutively-active PKD1 (PKD1.CA) and vector, HA-tagged PIP5Klγ or PIP5Klγ.S448A as indicated. PIP5Klγ was immunoprecipitated (anti-HA) and assessed for PKD1-mediated phosphorylation using the pMOTIF antibody which recognizes phosphorylated PKD substrates.
Immunoprecipitates were re-probed with anti-HA for equal loading of PIP5Klγ and PIP5Klγ.S448A. Lysates were evaluated for PKD1.CA expression (anti-FLAG). C: HeLa cells (0.25 x 10 6 cells/well, 6 well plate) were co-transfected with vector control or FLAG-tagged constitutively-active PKD1 (PKD1.CA) and vector, HA-tagged PIP5Klγ or PIP5Klγ.S448A, as indicated. PIP5Klγ was immunoprecipitated (anti-HA) and assessed for PKD1-mediated phosphorylation using a pS448-PIP5Klγ antibody. Immunoprecipitates were re-probed with anti-HA for equal loading of PIP5Klγ and PIP5Klγ.S448A. The lysates were evaluated for PKD1 expression (anti-PKD1). Hek293T cells (0.6 x 10 6 cells/well, 6 well plate) were transfected with HA-tagged PIP5Klγ, and stimulated with PMA (500 nM, 15 min), CRT0066101 (2.5 μM, 60 min) or DMSO control as indicated. Cell lysates were probed for PIP5Klγ phosphorylation (anti-pS448-PIP5Klγ) and reprobed for total PIP5Klγ (anti-HA). Control blots were probed for β-actin. B: Hek293T cells (0.5 x 10 6 cells/well, 6 well plate) were co-transfected with HA-tagged PIP5Klγ along with vector control, FLAG-tagged constitutively-active PKD1 (PKD1.CA), FLAG-tagged constitutively-active PKD2 (PKD1.CA), or GST-tagged constitutively-active PKD3 (PKD3.CA). An anti-HA antibody was used to immunoprecipitate PIP5Klγ from cells. Immunoprecipitates were subjected to SDS PAGE, and assessed using a pS448-PIP5Klγ antibody. Samples were counterstained for total PIP5Klγ using an anti-HA antibody. Control blots were performed for PKD1/2 (anti-FLAG), PKD3 (anti-GST) and β-actin expression.
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Supplemental Figure S6 , relates to Figure 4 : PKD1-mediated phosphorylation of S448 occurs in response to Fibronectin-RhoA signaling. A: HeLa cells (0.25 x 10 6 cells/well, 6 well plate) were cotransfected with HA-tagged PIP5Klγ, vector or FLAG-tagged PKD1 and vector or GST-tagged active RhoA (RhoA.CA), as indicated. PIP5Klγ was immunoprecipitated (anti-HA) and analyzed using pS448-PIP5Klγ antibody. Samples were re-probed with anti-HA to determine PIP5Klγ loading. Control blots were probed for PKD1, RhoA.CA (anti-GST) and β-actin expression. B: HeLa cells (0.25 x 10 6 cells/well, 6 well plate) were co-transfected with HA-tagged PIP5Klγ and vector control or GST-tagged active RhoA (RhoA.CA). Cells were stimulated with CRT0066101 (500 nM, 16 hours) or left untreated as indicated. PIP5Klγ was immunoprecipitated (anti-HA) and analyzed using the pS448-PIP5Klγ antibody. Immunoprecipitates were re-probed for total PIP5Klγ (anti-HA). Control blots were probed for RhoA.CA (anti-GST) and β-actin expression.
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